ArticleACS omega2026
Identification of Gβ5 Interactome Associated with Neuronal Development in Neuro-2a Cells through miniTurbo Proximity Labeling.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gβ5 is a member of the Gβ family; however, unlike other heterotrimeric Gβ proteins, which transduce extracellular signals in response to G-protein coupled receptor (GPCR) activation, Gβ5 negatively regulates GPCR signaling by stabilizing the GTPase-activating proteins (GAP) R7 subfamily of Regulator of G-protein Signaling (R7-RGS) proteins. Mutations in Gβ5 have been implicated in a multisystem developmental disorder. While the regulation of GPCR signaling at the plasma membrane is likely important in this process, Gβ5/R7-RGS also localizes to the cytosol and nucleus. Potential protein-protein interactions of Gβ5 in these subcellular compartments are not well studied, so we sought to characterize the interactome of Gβ5 utilizing a live-cell biotin proximity-labeling assay in Neuro-2a cells coupled with mass spectrometry to identify novel protein interactions of the complex. We identified 48 potential interactors of Gβ5 with two analysis methods, most of which are previously unreported interactions important in neuronal development and function. The enriched phenotypes associated with the Gβ5 interactome in our results align with previously reported phenotypes of Gβ5 deficiencies.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.